India’s largest pharmaceutical company Sun Pharmaceutical Industries Ltd. has acquired US-based Organon & Co. in an all-cash transaction, with an…
Read More
Drug manufacturing deals relocate to Europe despite pharma tariffs
Despite a federal push for onshoring and pharmaceutical import tariffs, biopharma companies have continued to increase their reliance on…
Read More
Trump orders new pharma tariff, reshapes metal duties
US President Donald Trump signed new tariff orders on the anniversary of ‘Liberation Day,’ when he imposed sweeping duties on…
Read More
Tech, Travel and Pharma Jolt Investor Sentiment
Global equity markets are trading nervously as heavyweight names from technology, aviation, payments, pharmaceuticals and banking reshape risk appetite, with…
Read More
Kiran Mazumdar-Shaw: The Biotech Pioneer Who Built Biocon into a Global Pharma Powerhoutilize
Kiran Mazumdar-Shaw stands as one of India’s most influential business leaders, widely recognized for transforming the biotechnology landscape. As the…
Read More
Getting Ready For The EU Pharma Package: Key Changes To Regulatory Exclusivities, Orphan Medicinal Products And The “Bolar” Exemption Provisions – Life Sciences, Biotechnology & Nanotechnology
After the Council and the European Parliament have reached an agreement in the trilogue neobtainediations on the so-called Pharma Package…
Read More
The Low-Profile Pharma Stock US Investors Are Sleeping On
Everyone is watching Big Tech, but a quiet Italian pharma player is pushing into rare diseases and US markets. Is…
Read More
EU court dismisses pharma call to annul disputed wastewater rules
Ruling leaves “important legal questions regarding the validity of the Directive unresolved”, according to indusattempt association EFPIA. Since its implementation…
Read More
EU-India trade deal: Opportunity for India’s pharma sector | Lucknow News
The EU-India Free Trade Agreement, concluded recently after nearly two decades of nereceivediation, holds the promise of reshaping global pharmaceutical…
Read More
Why pharma manufacturers are still investing in Europe
Tariffs and regulations of pharmaceutical manufacturing, far from deterring investment, are enticing foreign and domestic CMDOs to establish production on…
Read More
